1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 03 AUGUST 2015

Key Pharma News 03 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 38 pages

Industry Trend Analysis - Oncology Will Be Driving Force Of BMS' Revenues
Industry Trend Analysis - Hanmi Deal Underscores BI's Commitment To Core Competencies
Industry Brief - Genzyme To Acquire Caprelsa From AstraZeneca
Industry Brief - Regeneron/Sanofi Launch Major New Immuno-Oncology Collaboration
Industry Trend Analysis - Gilead Branching Out But Roots Will Continue To Grow Revenues
Industry Trend Analysis - Allergan Strengthens Mental Health Pipeline But Transformational Deal Ahead
Industry Brief - Eisai To Transfer North Carolina Plant To Biogen
Industry Brief - Baxalta Completes Oncaspar Portfolio Acquisition From Sigma-Tau
Industry Trend Analysis - M&A Activity Ahead For Biogen
Industry Trend Analysis - Actemra/RoActemra Sales Will Overtake MabThera/Rituxan In Roche's Immunology Portfolio In FY15
Industry Trend Analysis - Teva/Allergan Deal Will Reopen Mylan/Perrigo Transaction And End Actavis' Generics Business
Industry Brief - Merck Strengthens Immuno-Oncology Portfolio With cCAM Biotherapeutics Acquisition
Industry Trend Analysis - Mosquirix Sets Benchmark But Challenges Await
Industry Brief - Vibativ Approved In Canada For HABP/VABP
Industry Brief - FDA Accepts Merck's Grazoprevir/Elbasvir NDA
Industry Brief - CHMP Issues Positive Opinion On Synflorix Label Expansion
Industry Brief - Merck's Zerbaxa Gains CHMP Positive Opinion
Industry Brief - FDA Approves BMS' Daklinza For HCV GT3
Industry Brief - Janssen Submits sNDA To FDA For Olysio
Industry Brief - EMA Accepts Grazoprevir/Elbasvir MAA For Review In cHCV
Industry Brief - Teva Successfully Files MAA For Reslizumab
Industry Brief - Eisai Submits Fycompa NDA In Japan For Partial Onset/PGTC Seizures
Industry Brief - CHMP Recommends European Approval Of Praluent For Hypercholesterolaemia
Industry Brief - Keytruda Gains EU Approval For Advanced Melanoma
Industry Brief - CHMP Adopts Positive Opinion For Zalviso
Industry Brief - EC Approves Nivolumab BMS For Previously-Treated Advanced Squamous NSCLC
Industry Brief - Ono Seeks NSCLC Approval For Opdivo In Japan
Industry Brief - Final NICE Guidance Recommends BI's Vargatef
Industry Trend Analysis - Evotaz' Lack Of Competing Power Underscores Importance Of BMS' De-Diversification
Industry Trend Analysis - Resubmitted Sustol Will Be Growth Driver In CINV Drugs Market
Industry Brief - Amgen's Repatha Gains EU Approval
Industry Trend Analysis - US Biosimilar Market Tangible But Zarxio's Acceptance Will Be Challenging
Industry Brief - CHMP Recommends Approval Of Basilea's Cresemba In EU
Industry Brief - FDA Approval Sought For Arzerra As Maintenance Therapy For Relapsed CLL
Industry Brief - Tafinlar+Mekinist Gains CHMP Positive Opinion/FDA Priority Review For Advanced Melanoma
Industry Brief - EMA Validates Empliciti MAA For MM
Industry Brief - EMA Validates Two Parallel Type II Variation Applications To Extend Opdivo Indication
Industry Trend Analysis - Looming Competition Overshadows Kyprolis' Expanded Indication
Industry Trend Analysis - Limited Options Will Enable Odomzo To Take Market Share
Industry Trend Analysis - Par Will Fight To Retain Megace ES Market Share Despite Falling Sales
Industry Brief - Cresemba Phase III Study In Candida Infections Misses Primary Endpoint
Industry Brief - AstraZeneca’s Selumetinib Phase III Study In Uveal Melanoma Misses Primary Endpoint
Industry Trend Analysis - TAF To Strengthen Gilead's HIV Powerhouse Status
Industry Brief - BMS Gains FDA Breakthrough Designation For HIV-1 Attachment Inhibitor
Industry Trend Analysis - Data Keep Hopes Alive For Lilly's Solanezumab
Industry Trend Analysis - Positive Phase II Blincyto Data Will Secure Second FDA Nod
Industry Trend Analysis - Exelixis Will Finally See Success With Cabozantinib
Industry Trend Analysis - Opdivo Poised To Capitalise On Untapped RCC Market
Industry Brief - Lenvima Granted FDA Breakthrough Designation For RCC

Table Of Contents

Key Pharma News 03 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.